| Goods and Services | Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema,
fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma
fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and
prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations
for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of
hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia;
blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary
medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits
consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell
cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for
medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for
the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations,
namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibody
for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely,
antibody for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations, namely, for the treatment of Hereditary
Angioedema, HAE, respiratory diseases, acute respiratory distress syndrome, ARDS, Idiopathic Pulmonary Fibrosis, IPF and
Interstitial Lung Diseases, ILD |
